TELEPAQUE Drug Patent Profile
✉ Email this page to a colleague
When do Telepaque patents expire, and what generic alternatives are available?
Telepaque is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in TELEPAQUE is iopanoic acid. There is one drug master file entry for this compound. Additional details are available on the iopanoic acid profile page.
Summary for TELEPAQUE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Patent Applications: | 1,624 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TELEPAQUE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TELEPAQUE
US Patents and Regulatory Information for TELEPAQUE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | TELEPAQUE | iopanoic acid | TABLET;ORAL | 008032-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |